Publications by authors named "S M Ksiazek"
Chronic kidney disease (CKD) is a progressive condition that affects more than 10% of the population worldwide, accounting for more than 843 million (M) individuals. The prevalence of CKD (844 M patients) is higher than that of diabetes mellitus (422 M patients), cancer (42 M patients), and HIV (37 M patients), but people are often less aware of it. Global expert groups predict reductions in the nephrology workforce in the next decade, with a declining interest in nephrology careers.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on the use of central venous catheters (CVCs) in chronic hemodialysis patients in Vienna, noting that this practice is still common despite the preference for arteriovenous (AV) fistulas.
- A cross-sectional analysis of 335 CVC-based hemodialysis patients revealed a 42.5% prevalence of CVC use, with most patients eligible for either AV fistula or graft creation.
- The findings suggest that improving access to in-house vascular surgery could reduce reliance on CVCs and associated complications in hemodialysis patients in Vienna.
Background: Chronic kidney disease (CKD) burden is crucial both on a global scale and at individual patient level, affecting morbidity and mortality directly and through its effect on both cardiovascular damage and CKD progression to end-stage-kidney-disease (ESKD). Unfortunately, the awareness of CKD is poor, with few CKD patients conscious of the severity of their health status. The principal biomarker of kidney function is estimated glomerular filtration rate (eGFR).
View Article and Find Full Text PDF5-Amino salicylic acid (5-ASA) is a known culprit for the development of tubulointerstitial nephritis. Together with impaired kidney function, tubulointerstitial nephritis can lead to specific tubular malfunctions including distal renal tubular acidosis. Distal renal tubular acidosis is an acid-base disorder in which acid secretion in the distal part of the renal tubular system is decreased.
View Article and Find Full Text PDFRenin-angiotensin-aldosterone system (RAAS) inhibitors are standard care in patients with hypertension, heart failure or chronic kidney disease (CKD). Although we have studied the RAAS for decades, there are still circumstances that remain unclear. In this review, we describe the evolution of the RAAS and pose the question of whether this survival trait is still necessary to humankind in the present age.
View Article and Find Full Text PDF